Research Analysts’ New Coverage for July 22nd (COIN, ELOX, FOA, GNRC, HITI, IMBBY, IMMX, INFQ, JAPAY, NBIS)

Research Analysts’ new coverage for Wednesday, July 22nd:

Raymond James Financial, Inc. initiated coverage on shares of Coinbase Global (NASDAQ:COIN). The firm issued a market perform rating on the stock.

Lifesci Capital started coverage on shares of Eloxx Pharmaceuticals (NASDAQ:ELOX). They issued an outperform rating and a $40.00 target price on the stock.

Alliance Global Partners started coverage on shares of Finance of America Companies (NYSE:FOA). Alliance Global Partners issued a buy rating and a $30.00 target price on the stock.

Cantor Fitzgerald assumed coverage on shares of Generac (NYSE:GNRC). The firm issued an overweight rating and a $325.00 price target on the stock.

D. Boral Capital started coverage on shares of High Tide (NASDAQ:HITI). D. Boral Capital issued a buy rating and a $4.00 target price on the stock.

BTIG Research initiated coverage on shares of Imperial Tobacco Group (OTCMKTS:IMBBY). The firm issued a neutral rating on the stock.

Needham & Company LLC started coverage on shares of Immix Biopharma (NASDAQ:IMMX). Needham & Company LLC issued a buy rating and a $21.00 target price on the stock.

Craig Hallum started coverage on shares of Infleqtion (NYSE:INFQ). The firm issued a buy rating and a $19.00 target price on the stock.

BTIG Research started coverage on shares of Japan Tob (OTCMKTS:JAPAY). BTIG Research issued a buy rating on the stock.

Robert W. Baird began coverage on shares of Nebius Group (NASDAQ:NBIS). They issued an outperform rating and a $250.00 price target on the stock.

Canaccord Genuity Group Inc. assumed coverage on shares of Nektar Therapeutics (NASDAQ:NKTR). The firm issued a buy rating and a $153.00 price target on the stock.

Alliance Global Partners began coverage on shares of High Roller Technologies (NYSEAMERICAN:ROLR). The firm issued a buy rating and a $20.00 price target on the stock.

Evercore Inc started coverage on shares of Tenax Therapeutics (NASDAQ:TENX). Evercore Inc issued an outperform rating and a $39.00 target price on the stock.